Summary Slide.png (129.13 kB)
Download fileDupilumab Maintains Long-Term Disease Control in Adults With Moderate to Severe Atopic Dermatitis as Measured by Well-Controlled Weeks: Results From the LIBERTY AD CHRONOS Clinical Trial
media
posted on 2021-01-22, 09:53 authored by Adis journals on behalf of, Jashin J. Wu, Lynda Spelman, Jerry L. Tan, Takafumi Etoh, Haixin Zhang, Brad Shumel, Ana B. Rossi
Article full text
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021.
